Cover Image

Identification of a novel NF1 deletion variant in a Taiwanese boy with neurofibromatosis type 1-associated Moyamoya syndrome

Saved in:

Bibliographic Details
Main Authors:	Yung-Yu Yang (Author), Chia-Hsiang Yu (Author), Chih-Fen Hu (Author), Chia-Cheng Sung (Author), Shyi-Jou Chen (Author)
Format:	Book
Published:	Elsevier, 2023-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient
by: Natália Battisti Serafini, et al.
Published: (2017)

Identification of NF1 Frameshift Variants in Two Chinese Families With Neurofibromatosis Type 1 and Early-Onset Hypertension
by: Yi-Ting Lu, et al.
Published: (2021)

Chinese patient with neurofibromatosis-Noonan syndrome caused by novel heterozygous NF1 exons 1-58 deletion: a case report
by: Zhen Zhang, et al.
Published: (2020)

Optic Pathway Gliomas in Neurofibromatosis 1 (NF-1)
by: J Gordon Millichap
Published: (2007)

The Perceived Influence of Neurofibromatosis Type 1(NF1) on the Parents' Relationship
by: Lori Wiener, et al.
Published: (2023)

A Novel Heterozygous NF1 Variant in a Neurofibromatosis-Noonan Syndrome Patient with Growth Hormone Deficiency: A Case Report
by: Si Qin, et al.
Published: (2023)

Neonatal seizure caused by periventricular leukomalacia resulting from maternal protein S deficiency and treated with aspirin
by: Chun-Hao Chu, et al.
Published: (2022)

Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1)
by: Peter L. Stavinoha, et al.
Published: (2021)

Intravenous Pamidronate Therapy in Taiwanese Patients with Osteogenesis Imperfecta
by: Hsiang-Yu Lin, et al.
Published: (2008)

Clinical characteristics and spectrum of NF1 mutations in 12 unrelated Chinese families with neurofibromatosis type 1
by: Bin Mao, et al.
Published: (2018)

Neurofibromatosis Type 1 (NF1): Addressing the Transition from Pediatric to Adult Care
by: Radtke HB, et al.
Published: (2023)

Case report: Revascularization failure in NF1-related moyamoya syndrome after selumetinib: A possible pathophysiological correlation?
by: Cristina Chelleri, et al.
Published: (2023)

Interleukin-1β gene is not associated with preeclampsia in Taiwanese
by: Lin Kang, et al.
Published: (2012)

Prevalence of developmental maxillary midline diastema in Taiwanese children
by: Jeng-Fen Liu, et al.
Published: (2013)

Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review
by: Xin Liao, et al.
Published: (2017)

NF1 Gene Novel Splicing Mutations in a Chinese Family with Neurofibromatosis Type 1: Case Series
by: Wu T, et al.
Published: (2022)

Case Report: First Case of Non-restrictive Ventricular Septal Defect With Congestive Heart Failure in a Chinese Han Male Infant Carrying a Class II Chromosome 17p13.3 Microduplication
by: Yung-Yu Yang, et al.
Published: (2022)

Moyamoya Disease
by: J Gordon Millichap
Published: (1989)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
by: Claudia Santoro, et al.
Published: (2018)

Targeted exon skipping of NF1 exon 17 as a therapeutic for neurofibromatosis type I
by: André Leier, et al.
Published: (2022)

Successful infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in two Taiwanese children: An experience from a medical center
by: Chun-Ting Liu, et al.
Published: (2024)

Childhood-Onset Refractory Hypertension Results from Neurofibromatosis Type 1 Caused by a Splicing NF1 Mutation
by: Yi-Ting Lu, et al.
Published: (2023)

Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1
by: Peiwei Chai, et al.
Published: (2019)

The efficacy of statins for improving cognitive impairments in pediatric patients with neurofibromatosis type 1 (NF-1): a meta-analysis
by: Lutong Gan, et al.
Published: (2023)

Neurofibromatosis type 1
by: P Chaitra, et al.
Published: (2013)

Neurofibromatosis type 1
by: P Chaitra, et al.
Published: (2013)

Deletion of intestinal SIRT1 exacerbated muscle wasting in cirrhotic mice by decreasing the intestinal concentration of short-chain fatty acids and inflammation
by: Chien-Fu Hsu, et al.
Published: (2021)

Novel, heterozygous, de novo pathogenic variant (c.4963delA: p.Thr1656Glnfs*42) of the NF1 gene in a Chinese family with neurofibromatosis type 1
by: Lisha Yang, et al.
Published: (2023)

The Moyamoya disease - the description of clinical case = Choroba moyamoya - opis przypadku klinicznego
by: Kamila Woźniak, et al.
Published: (2015)

The Moyamoya disease - the description of clinical case = Choroba moyamoya - opis przypadku klinicznego
by: Kamila Woźniak, et al.
Published: (2015)

Mosaic neurofibromatosis type 1 or segmental neurofibromatosis: what is in the name?
by: Kakar Shruti, et al.
Published: (2022)

Surgery of Moyamoya Disease
by: J Gordon Millichap
Published: (1994)

Population pharmacokinetics of FCN-159, a MEK1/2 inhibitor, in adult patients with advanced melanoma and neurofibromatosis type 1 (NF1) and model informed dosing recommendations for NF1 pediatrics
by: Yan Tan, et al.
Published: (2023)

Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex
by: Britt A. E. Dhaenens, et al.
Published: (2024)

Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I
by: Kairong Li, et al.
Published: (2016)

Tourette's Syndrome and Neurofibromatosis 1
by: J Gordon Millichap
Published: (2000)

Cardiopulmonary functional capacity in Taiwanese children with ventricular septal defects
by: Yen-Sen Lu, et al.
Published: (2023)

Correlation between large rearrangements and patient phenotypes in NF1 deletion syndrome: an update and review
by: Laurence Pacot, et al.
Published: (2024)

Neurofibromatosis Type 1 and Hypospadias in a Male 46, XY with a Mutation in the NF1 Gene and a Mutation in NR5A1
by: Perafan-Valdes L, et al.
Published: (2022)

Nonsteroidal sulfamate derivatives as new therapeutic approaches for Neurofibromatosis 2 (NF2)
by: Yu-chi Shen, et al.
Published: (2019)